A comparison of two methods to assess audience-induced changes in male mate choice M Ziege, C Hennige-Schulz, F Muecksch, D Bierbach, R Tiedemann, ... Current Zoology 58 (1), 84-94, 2012 | 8 | 2012 |
A recombinant protein SARS-CoV-2 candidate vaccine elicits high-titer neutralizing antibodies in macaques. G Baisa, D Rancour, K Mansfield, M Burns, L Martin, D Cunha, J Fischer, ... bioRxiv, 2021 | 8 | 2021 |
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations F Muecksch, Y Weisblum, CO Barnes, F Schmidt, D Schaefer-Babajew, ... Immunity 54 (8), 1853-1868. e7, 2021 | 256 | 2021 |
Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins Z Wang, F Muecksch, A Cho, C Gaebler, HH Hoffmann, V Ramos, S Zong, ... Immunity 55 (6), 998-1012. e8, 2022 | 92 | 2022 |
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination A Cho, F Muecksch, D Schaefer-Babajew, Z Wang, S Finkin, C Gaebler, ... Nature 600 (7889), 517-522, 2021 | 271 | 2021 |
Antibody evolution to SARS-CoV-2 after single-dose Ad26. COV2. S vaccine in humans A Cho, F Muecksch, Z Wang, TB Tanfous, J DaSilva, R Raspe, B Johnson, ... The Journal of experimental medicine 219 (8), 2022 | 14 | 2022 |
Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination D Schaefer-Babajew, Z Wang, F Muecksch, A Cho, M Loewe, M Cipolla, ... Nature 613 (7945), 735-742, 2023 | 64 | 2023 |
Antibody feedback regulation of memory B cell development in SARS-CoV-2 mRNA vaccination D Schaefer-Babajew, Z Wang, F Muecksch, A Cho, R Raspe, B Johnson, ... medRxiv, 2022 | 12 | 2022 |
Antibody potency, effector function and combinations in protection from SARS-CoV-2 infectionin vivo A Schäfer, F Muecksch, JCC Lorenzi, SR Leist, M Cipolla, S Bournazos, ... | 2 | 2020 |
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo A Schäfer, F Muecksch, JCC Lorenzi, SR Leist, M Cipolla, S Bournazos, ... The Journal of experimental medicine 218 (3), 2021 | 318 | 2021 |
Antigen presentation dynamics shape the antibody response to variants like SARS-CoV-2 Omicron after multiple vaccinations with the original strain L Yang, M Van Beek, Z Wang, F Muecksch, M Canis, T Hatziioannou, ... Cell Reports 42 (4), 2023 | 19 | 2023 |
Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain L Yang, M Van Beek, Z Wang, F Muecksch, M Canis, T Hatziioannou, ... bioRxiv, 2022 | 4 | 2022 |
Aparición en vacunados de infecciones con variantes del SARS-CoV-2 BSN Bergh, EG Conlon, DJ Schaefer‑Babajew, J DaSilva, F Muecksch, ... | | |
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV JF Scheid, CO Barnes, B Eraslan, A Hudak, JR Keeffe, LA Cosimi, ... Cell 184 (12), 3205-3221. e24, 2021 | 91 | 2021 |
Bispecific antibody prevents SARS-CoV-2 escape and protects mice from disease R De Gasparo, M Pedotti, L Simonelli, P Nickl, F Muecksch, I Cassaniti, ... | 3* | 2021 |
Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice GR DE, M PEDOTTI, L SIMONELLI, P NICKL, F MUECKSCH, ... | | |
Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice R De Gasparo, M Pedotti, L Simonelli, P Nickl, F Muecksch, I Cassaniti, ... Nature 593 (7859), 424-428, 2021 | 126 | 2021 |
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies CA Jette, AA Cohen, PNP Gnanapragasam, F Muecksch, YE Lee, ... Cell reports 36 (13), 2021 | 108 | 2021 |
Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry ER Kastenhuber, M Mercadante, B Nilsson-Payant, JL Johnson, ... Elife 11, e77444, 2022 | 55 | 2022 |
Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland L McDonald, H Wise, F Muecksch, D Poston, S Mavin, K Templeton, ... Journal of Clinical Virology Plus 1 (3), 100028, 2021 | 2 | 2021 |